Fundraising Fox

Immune-Onc Therapeutics

Palo Alto, US · Founded 2015 · Delaware corporation · 3 known investors

immune-onc.com ↗

Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.

BiotechMedical Devices

Founders & leadership

XC
Xiaoling Charlene LiaoExecutive Officer, Director
GY
Guo-Liang YuDirector
LL
Liqun LuoDirector

Investors · 3

Northern Light Venture CapitalMenlo Park · $1.3M – $100M
ShangBay Capital LLCPalo Alto
Vivo CapitalPalo Alto · $10M – $50M

Reported raises · per SEC filings

Form D private placements
▶$7MraisedSep 2016 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Xiaoling Charlene LiaoExecutive Officer, Director
  • Guo-Liang YuDirector
  • Liqun LuoDirector
Offering amount
$7M
Amount sold
$7M
Minimum investment
$1
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news